Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Joyzyme GroupHKSE:08622 +3.13%40 PB Ratio is 1.50 as of Aug. 28, 2026, which is 27% above its 10-year median of 1.18. GuruFocus rates HKSE:08622 with a GF Score™ of 40/100 and a GF Value™ of HK$0.17 (Fairly Valued). The stock has 4 warning signs investors should review. Among 918 Drug Manufacturers companies, Joyzyme Group ranks better than 62.42% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-08-28), Joyzyme Group's share price is HK$0.165. Joyzyme Group's Book Value per Share for the quarter that ended in Dec. 2025 was HK$0.11. Hence, Joyzyme Group's PB Ratio of today is 1.50.
Good Sign:
Joyzyme Group Ltd stock PB Ratio (=1.49) is close to 1-year low of 1.49.
The historical rank and industry rank for Joyzyme Group's PB Ratio or its related term are showing as below:
HKSE:08622'
s PB Ratio Range Over the Past 10 Years
Min: 0.48 Med: 1.18 Max: 4.78
Current: 1.5
During the past 11 years, Joyzyme Group's highest PB Ratio was 4.78. The lowest was 0.48. And the median was 1.18.
HKSE:08622's PB Ratio is ranked better than 62.42% of 918
companies
in the Drug Manufacturers industry
Industry Median: 1.97
vs HKSE:08622: 1.50
During the past 12 months, Joyzyme Group's average Book Value Per Share Growth Rate was -4.30% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -10.20% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -10.70% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 5.80% per year.
During the past 11 years, the highest 3-Year average Book Value Per Share Growth Rate of Joyzyme Group was 62.60% per year. The lowest was -13.40% per year. And the median was -6.30% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Joyzyme Group PB Ratio Related Terms
Joyzyme Group PB Ratio Historical Data
* Premium members only.
The historical data trend for Joyzyme Group's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Joyzyme Group's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Joyzyme Group PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Joyzyme Group's PB Ratio distribution charts can be found below:
* The bar in red indicates where Joyzyme Group's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Joyzyme Group's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Joyzyme Group (HKSE:08622) has a PB Ratio of 1.50 as of Aug. 28, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Joyzyme Group and its competitors. This is 27% above median its historical median of 1.18. Over the past decade, Joyzyme Group's PB Ratio has ranged from 0.48 to 4.78. According to the industry distribution chart, Joyzyme Group ranks #345 out of 918 companies in the Drug Manufacturers industry, placing it in the top 37.6%.
Is Joyzyme Group's PB Ratio too high?
Joyzyme Group's current PB Ratio of 1.50 is 27% above median its 10-year median of 1.18. Over the past 10 years, this metric has ranged from a low of 0.48 to a high of 4.78. The Drug Manufacturers industry median PB Ratio is 1.97. Joyzyme Group's value of 1.50 is 23.9% below this industry median. Based on the distribution chart, Joyzyme Group ranks #345 out of 918 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Joyzyme Group has a GF Score™ of 40/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Joyzyme Group's PB Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Joyzyme Group ranks #345 out of 918 companies for PB Ratio. This puts Joyzyme Group in the upper half of its industry. The industry median PB Ratio is 1.97. Joyzyme Group's value of 1.50 is 23.9% below this benchmark. Historically, Joyzyme Group's own PB Ratio has ranged from 0.48 to 4.78 over the past decade. While the company's 10-year median is 1.18 vs. the industry median of 1.97, Joyzyme Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.97, based on 918 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Joyzyme Group's current PB Ratio of 1.50 is 23.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Joyzyme Group and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Joyzyme Group's current PB Ratio is 1.50, which is 27% above median its own 10-year median of 1.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Joyzyme Group stock overvalued right now?
Based on GuruFocus' analysis, Joyzyme Group (HKSE:08622) is currently considered Fairly Valued. The stock's GF Value™ is HK$0.17, compared to a current price of HK$0.17 — trading 2.9% below its estimated fair value. The current PB Ratio is 1.50, which is 27% above median its 10-year median of 1.18 and 23.9% below the Drug Manufacturers industry median of 1.97. Joyzyme Group's overall GF Score™ is 40/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Joyzyme Group (HKSE:08622), the current PB Ratio is 1.50 as of Aug. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Joyzyme Group (HKSE:08622) Overvalued in 2026?
Based on GuruFocus' analysis, Joyzyme Group stock appears to be undervalued.
The current stock price of HK$0.17 is trading 2.9% below its estimated GF Value™ of HK$0.17.
GuruFocus considers Joyzyme Group to be Fairly Valued.
Key valuation signals for HKSE:08622:
PB Ratio: 1.50 (27% above median its 10-year median of 1.18)
GF Value™: HK$0.17 vs. price of HK$0.17 (2.9% below fair value)
Industry Position: 23.9% below the Drug Manufacturers median (#345 of 918)
No single metric tells the full story. See the HKSE:08622 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AddressNo.16 Yinkui Road, 1-3 floor and 5th floor, Building D, Shenzhen Junxuan, Kui Xin Community, Kui Chong Office, Dapeng New District, Shenzhen, CHN
Joyzyme Group Ltd is an investment holding company. The Company and its subsidiaries are principally engaged in research and development, manufacture, marketing, and sale of biological reagents and auxiliary reproductive supplies and equipment, and healthcare products and supplements in the People's Republic of China (the PRC). It operates in two segments: Biological reagents and auxiliary reproductive supplies and equipment, and Healthcare products and supplements. It generates the majority of its revenue from the biological reagents and auxiliary reproductive supplies and equipment segment. Geographically, it generates revenue from the PRC.
40GF Score
Get the complete analysis for HKSE:08622
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:08622 has been successfully added to your 
